Literature DB >> 7236993

Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.

N J Cusack, S M Hourani.   

Abstract

1 RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) ((R)-ADP-alpha-S and (S)-ADP-alpha-S), an adenosine 5'-diphosphate (ADP) analogue, were tested on intact human platelets. 2 Each diastereoisomer induced aggregation, (S)-ADP-alpha-S being 5 times more potent than (R)-ADP-alpha-S but they achieved only 75% of the maximal effect of ADP. 3 Aggregation induced by each diastereoisomer was competitively inhibited by ATP (50 microM). 4 Simultaneous addition of each diastereoisomer inhibited aggregation induced by ADP but not by 11 alpha, 9 alpha-epoxymethano prostaglandin H2, a stable endoperoxide analogue. Both diastereoisomers are therefore partial agonists at the ADP receptor mediating aggregation. 5 Unlike ADP, neither diastereoisomer inhibited prostaglandin E1 (PGE1)-stimulated adenylate cyclase, but each competitively inhibited the effect of aDP, with (S)-ADP-alpha-S again being 5 times more potent than (R)-ADP-alpha-S. 6 These are the first reported examples of ADP analogues to induce platelet aggregation without inhibiting PGE1-stimulated adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236993      PMCID: PMC2071675          DOI: 10.1111/j.1476-5381.1981.tb10437.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets.

Authors:  A GAARDER; J JONSEN; S LALAND; A HELLEM; P A OWREN
Journal:  Nature       Date:  1961-11-11       Impact factor: 49.962

2.  Synthesis and properties of diastereoisomers of adenosine 5'-(O-1-thiotriphosphate) and adenosine 5'-(O-2-thiotriphosphate).

Authors:  F Eckstein; R S Goody
Journal:  Biochemistry       Date:  1976-04-20       Impact factor: 3.162

3.  Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.

Authors:  R J Haslam; G M Rosson
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

4.  The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.

Authors:  D E Macfarlane; D C Mills
Journal:  Blood       Date:  1975-09       Impact factor: 22.113

5.  Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.

Authors:  D E MacIntyre; E W Salzman; J L Gordon
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

6.  Absolute configuration of the diastereomers of adenosine 5'-O-(1-thiotriphosphate): consequences for the stereochemistry of polymerization by DNA-dependent RNA polymerase from Escherichia coli.

Authors:  P M Burgers; F Eckstein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  Interactions of the pharmacological receptors of blood platelets with adenylate cyclase.

Authors:  R J Haslam
Journal:  Ser Haematol       Date:  1973

8.  High-pressure liquid chromatography of modified purine mononucleotides and nucleosides.

Authors:  K W Stahl; E Schlimme; D Bojanowski
Journal:  J Chromatogr       Date:  1973-08-29

9.  Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma.

Authors:  F Michal; G V Born
Journal:  Nat New Biol       Date:  1971-06-16

10.  Effects of D- and L- enantiomers of adenosine, AMP and ADP and their 2-chloro- and 2-azido- analogues on human platelets.

Authors:  N J Cusack; M E Hickman; G V Born
Journal:  Proc R Soc Lond B Biol Sci       Date:  1979-11-30
View more
  11 in total

1.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

3.  Studies on the stereoselectivity of the P2-purinoceptor on the guinea-pig vas deferens.

Authors:  G Burnstock; N J Cusack; L A Meldrum
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

4.  Mammalian platelet adrenoceptors.

Authors:  R Kerry; M C Scrutton; R B Wallis
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

5.  Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.

Authors:  D A Hall; S M Hourani
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Platelet beta-adrenoceptors.

Authors:  R Kerry; M C Scrutton
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

7.  Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

8.  Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea-pig taenia coli and urinary bladder.

Authors:  G Burnstock; N J Cusack; L A Meldrum
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

9.  Identification of a receptor for ADP on blood platelets by photoaffinity labelling.

Authors:  G Cristalli; D C Mills
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

10.  Stereoselectivity of ectonucleotidases on vascular endothelial cells.

Authors:  N J Cusack; J D Pearson; J L Gordon
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.